Viewing Study NCT00002059


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2025-12-27 @ 3:03 AM
Study NCT ID: NCT00002059
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers
Sponsor: Newport Pharmaceuticals International
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module